Deka Bank Deutsche Girozentrale Cara Therapeutics, Inc. Transaction History

Deka Bank Deutsche Girozentrale

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$11.99 - $18.14 $194,238 - $293,868	-16,200 Closed	0 $0
Q3 2020 Oct 29, 2020	BUY	$12.34 - $17.92 $199,908 - $290,304	16,200 New	16,200 $197,000
Q1 2020 May 14, 2020	SELL	$9.12 - $17.78 $433,199 - $844,550	-47,500 Closed	0 $0
Q4 2019 Feb 04, 2020	SELL	$16.11 - $25.98 $96,660 - $155,880	-6,000 Reduced 11.21%	47,500 $776,000
Q3 2019 Nov 14, 2019	SELL	$18.28 - $26.91 $109,680 - $161,460	-6,000 Reduced 10.08%	53,500 $997,000
Q2 2019 Aug 01, 2019	BUY	$17.68 - $21.57 $813,280 - $992,220	46,000 Added 340.74%	59,500 $1.26 Million
Q1 2019 May 10, 2019	BUY	$14.41 - $19.64 $36,025 - $49,100	2,500 Added 22.73%	13,500 $270,000
Q4 2018 Feb 12, 2019	SELL	$12.45 - $23.47 $31,125 - $58,675	-2,500 Reduced 18.52%	11,000 $143,000
Q1 2018 May 03, 2018	BUY	$11.77 - $16.08 $158,895 - $217,079	13,500 New	13,500 $164,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $16.7M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.